Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
27.91
-0.13 (-0.46%)
At close: Oct 24, 2025, 4:00 PM EDT
27.37
-0.54 (-1.93%)
After-hours: Oct 24, 2025, 4:11 PM EDT
Option Care Health Revenue
Option Care Health had revenue of $1.42B in the quarter ending June 30, 2025, with 15.39% growth. This brings the company's revenue in the last twelve months to $5.37B, up 17.06% year-over-year. In the year 2024, Option Care Health had annual revenue of $5.00B with 16.17% growth.
Revenue (ttm)
$5.37B
Revenue Growth
+17.06%
P/S Ratio
0.87
Revenue / Employee
$664,444
Employees
8,088
Market Cap
4.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.00B | 695.88M | 16.17% |
| Dec 31, 2023 | 4.30B | 357.59M | 9.06% |
| Dec 31, 2022 | 3.94B | 506.10M | 14.72% |
| Dec 31, 2021 | 3.44B | 406.03M | 13.39% |
| Dec 31, 2020 | 3.03B | 722.19M | 31.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OPCH News
- 4 weeks ago - Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call - GlobeNewsWire
- 2 months ago - Option Care Health To Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Option Care Health Announces Chief Financial Officer Transition - GlobeNewsWire
- 2 months ago - Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP - Business Wire
- 2 months ago - Option Care Health: Continued Value Erosion At Current Rate Of Growth - Seeking Alpha
- 3 months ago - Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025 - GlobeNewsWire
- 4 months ago - Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call - GlobeNewsWire